LogoPressRelease.jpg
Fluidigm to Participate at the 2020 Cantor Virtual Global Healthcare Conference
02 sept. 2020 16h02 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR  Assay for COVID-19
25 août 2020 23h00 HE | Fluidigm Corporation
Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment Extraction-Free, Real-Time PCR Workflow with Capacity of up to 6,000 Tests per Day per System  Demonstrated 100 Percent...
LogoPressRelease.jpg
Fluidigm Announces Second Quarter 2020 Financial Results
06 août 2020 16h05 HE | Fluidigm Corporation
Second Quarter Revenue Decreased 8 Percent to $26.1 Million Filed for FDA Emergency Use Authorization for COVID-19 Saliva-based Test Multi-Site U.S. Study of COVID-19 Patients Utilizes Mass...
Voltron.png
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19
08 juil. 2020 08h30 HE | Voltron Therapeutics, Inc.
NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today it has initiated preclinical animal testing of the first construct of its HaloVax Self-Assembling Vaccine (SAV)...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results
06 juil. 2020 16h02 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
20161212-MBX_logo_lrg.jpg
Microbix Announces Quality Products Distribution Agreement
04 juin 2020 07h00 HE | Microbix Biosystems Inc.
MISSISSAUGA, Ontario, June 04, 2020 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an award-winning life sciences innovator and exporter, announces the appointment of Alpha-Tec...
Annovis_Corp_Image.png
Annovis Bio Files Patent Application for Method of Inhibiting, Preventing, or Treating Neurological Injuries Due to Viral and Other Infections Including COVID-19
27 mai 2020 06h45 HE | Annovis Bio Inc.
BERWYN, Pa., May 27, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other...
ISHLT Elects Lara Danziger-Isakov President-Elect Addison, Texas, May 20, 2020 (GLOBE NEWSWIRE) -- Lara Danziger-Isakov MD, MPH, Director of Immunocompromised Host Infectious Disease at the Cincinnati Children’s Hospital Medical Center in...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Launches Rapid Restart™ Program
18 mai 2020 09h00 HE | Taconic Biosciences
RENSSELAER, N.Y., May 18, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid...
LogoPressRelease.jpg
Fluidigm to Present at Upcoming Health Care Investor Conferences
13 mai 2020 16h02 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...